Titre
Pharmacovigitance--pharmaco-epidemiologie. [Trends in drug therapy]
Type
synthèse (review)
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
Livio, F.
Auteure/Auteur
Buclin, T.
Auteure/Auteur
Biollaz, J.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1660-9379
Statut éditorial
Publié
Date de publication
2006-01
Volume
2
Numéro
48
Première page
155
Dernière page/numéro d’article
9
Notes
English Abstract
Journal Article
Review --- Old month value: Jan 11
Journal Article
Review --- Old month value: Jan 11
Résumé
This article reviews some recent aspects of pharmacovigilance, of interest to the practitioner: biphosphonates and osteonecrosis of the jaw, antidepressants and suicide, antipsychotics and increased mortality risk and cerebrovascular events, withdrawal syndrome after in utero exposure to antidepressants SSRI, NSAIDs and increased cardiovascular events, cancer and topical immunosuppressants, visual loss and treatment of erectile dysfunction, valvulopathy and dopaminergic agonists. Risk-benefit assessment of drugs is a dynamic process. One must keep in mind that the data on the relationship between drugs and the clinical picture are of variable quality and that the size of the risk is often difficult to assess.
Sujets
PID Serval
serval:BIB_A06661C6BF04
PMID
Date de création
2008-01-25T09:41:22.160Z
Date de création dans IRIS
2025-05-21T02:19:48Z